Author:
Hopper Samuel J.,Fernstrum Colton J.,Phillips John B.,Sink Matthew C.,Goza Shelby D.,Brown Madyson I.,Brown Kathryn W.,Humphries Laura S.,Hoppe Ian C.
Abstract
Objective
This study examines an Enhanced Recovery After Surgery (ERAS) protocol for patients with cleft palate and hypothesizes that patients who followed the protocol would have decreased hospital length of stay and decreased narcotic usage than those who did not.
Design
Retrospective cohort study.
Setting
The study takes place at a single tertiary children's hospital.
Patients
All patients who underwent cleft palate repair during a 10-year period (n = 242).
Interventions
All patients underwent cleft palate repair with the most recent cohort following a new ERAS protocol.
Main Outcome Measures
Primary outcomes included hospital length of stay and narcotic usage in the first 24 hours after surgery.
Results
Use of local bupivacaine during surgery was associated with decreased initial 24-hour morphine equivalent usage: 2.25 vs 3.38 mg morphine equivalent (MME) (P < 0.01), and a decreased hospital length of stay: 1.71 days vs 2.27 days (P < 0.01). The highest 24-hour morphine equivalent a patient consumed prior to the ERAS protocol implementation was 24.53 MME, compared with 6.3 MME after implementation. Utilization of the ERAS protocol was found to be associated with a decreased hospital length of stay: 1.67 vs 2.18 days (P < 0.01).
Conclusions
Use of the proposed ERAS protocol may lead to lower narcotic usage and decreased length of stay.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献